146 related articles for article (PubMed ID: 11334467)
21. Identification of mismatch repair protein complexes in HeLa nuclear extracts and their interaction with heteroduplex DNA.
Matton N; Simonetti J; Williams K
J Biol Chem; 2000 Jun; 275(23):17808-13. PubMed ID: 10748159
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair genes in renal cell carcinoma.
Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
24. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.
Shin KH; Park JG
Eur J Cancer; 2000 May; 36(7):925-31. PubMed ID: 10785599
[TBL] [Abstract][Full Text] [Related]
26. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
Wright CL; Stewart ID
Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
[TBL] [Abstract][Full Text] [Related]
27. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
[TBL] [Abstract][Full Text] [Related]
28. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
29. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
Catto JW; Xinarianos G; Burton JL; Meuth M; Hamdy FC
Int J Cancer; 2003 Jul; 105(4):484-90. PubMed ID: 12712438
[TBL] [Abstract][Full Text] [Related]
31. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
Balogh GA; Russo IH; Russo J
Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of hMSH2, hMSH3, and hMSH6 expression in ameloblastoma.
Amaral-Silva GKD; Sánchez-Romero C; Wagner VP; Martins MD; Pontes HAR; Fregnani ER; Soares FA; Almeida OP; Rocha AC; Santos-Silva AR; Fonseca FP; Vargas PA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):286-295. PubMed ID: 28734697
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
Shin KH; Shin JH; Kim JH; Park JG
Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
[TBL] [Abstract][Full Text] [Related]
34. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
35. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
Scartozzi M; Bianchi F; Rosati S; Galizia E; Antolini A; Loretelli C; Piga A; Bearzi I; Cellerino R; Porfiri E
J Clin Oncol; 2002 Mar; 20(5):1203-8. PubMed ID: 11870161
[TBL] [Abstract][Full Text] [Related]
36. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral melanoma.
Lo Muzio L; Nocini P; Mignogna MD; Pannone G; Staibano S; Procaccini M; Rubini C; Fioroni M; Fanali S; Piattelli A
Anticancer Res; 2000; 20(2A):741-8. PubMed ID: 10810349
[TBL] [Abstract][Full Text] [Related]
38. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line].
Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538
[TBL] [Abstract][Full Text] [Related]
39. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability.
Staebler A; Lax SF; Ellenson LH
Hum Pathol; 2000 Mar; 31(3):354-8. PubMed ID: 10746679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
